TITLE

Re: Melanoma in the GI Tract

AUTHOR(S)
Newman, John L.; Hemmings, Mary Beth; Watkins Jr., Stanley P.
PUB. DATE
August 2000
SOURCE
American Journal of Gastroenterology;Aug2000, Vol. 95 Issue 8, p2131
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor in response to the article "Melanoma in the Gastrointestinal Tract," by D. Blecker et al, in previous issue.
ACCESSION #
17652451

 

Related Articles

  • Expression of CD117 in Primary Anorectal Malignant Melanoma. Laforga, Juan B.; Gasent, Joan M. // Archives of Pathology & Laboratory Medicine;Feb2009, Vol. 133 Issue 2, p176 

    A letter to the editor is presented in response to the article "Expression of melanoma antigens in epithelioid gastrointestinal stromal tumors: a potential diagnostic pitfall," by ML Guler, JA Daniels, SC Abraham, and EA Montgomery in the 2008 issue.

  • Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk. Thirumaran, Ranjit K.; Thoelke, Adina; Ugurel, Selma; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv // JNCI: Journal of the National Cancer Institute;9/6/2006, Vol. 98 Issue 17, p1252 

    A letter to the editor is presented in response to the article "Association between endothelin receptor B non-synonymous variants and melanoma risk," by B. N. Soufir and colleagues, which appeared in a 2005 issue of the "Journal of the National Cancer Institute."

  • RESPONSE. Soijfir, Nadem // JNCI: Journal of the National Cancer Institute;9/6/2006, Vol. 98 Issue 17, p1253 

    A response by the authors to a letter to the editor about their article "Association between endothelin receptor B non-synonymous variants and melanoma risk," which appeared in a 2005 issue of the "Journal of National Cancer Institute" is presented.

  • Melanoma Cancer. Hege, Enas // Saturday Evening Post;Jul/Aug87, Vol. 259 Issue 5, p8 

    Presents a letter to the editor about melanoma cancer.

  • Ipilimumab plus Dacarbazine in Melanoma.  // New England Journal of Medicine;9/29/2011, Vol. 365 Issue 13, p1256 

    A letter to the editor is presented in response to an article about the addition of ipilimumab to dacarbazine chemotherapy as a first-line therapy for metastatic melanoma by Robert and colleagues, published in the June 30, 2011 issue.

  • Melanoma in Children. Bono, Aldo; Bartoli, Cesare; Del Prato, Ivan // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p255 

    A letter to the editor is presented in response to the article "Melanoma in Children," by Ceballos, Ruiz-Maldonado, and Mihm in the March 9, 1995 issue.

  • Melanoma in Children. Pappo, Alberto S.; Pratt, Charles B. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p255 

    A letter to the editor is presented in response to the article "Melanoma in Children," by Ceballos, Ruiz-Maldonado, and Mihm in the March 9, 1995 issue.

  • Melanoma in Children. Ceballos, Patricia I.; Ruiz-Maldonado, Ramon; Mihm, Martin C. // New England Journal of Medicine;7/27/95, Vol. 333 Issue 4, p255 

    A response by Ceballos, Ruiz-Maldonado, and Mihm to several letters to the editor about their article "Melanoma in Children" in the March 9, 1995 issue is presented.

  • Malignant melanoma. Schwartz, Stephen D. // Journal of Dermatologic Surgery & Oncology;May/Jun77, Vol. 3 Issue 3, p246 

    Presents a letter to the editor about malignant melanomas.

  • Capital Letters. Breslow, Alexander // Journal of Dermatologic Surgery & Oncology;May/Jun77, Vol. 3 Issue 3, p246 

    Presents a letter to the editor about Malignant Melanoma: A Review.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics